The Importance of Molecular Aspects to Make Therapeutic Decisions in Lung Cancer

 

 

As part of ESMO's continuous commitment to offering beneficial educational material relevant to your work and practice in order to receive your certificate, please complete the Evaluation Survey, which will take approximately 5 minutes. Please indicate which rating reflects your answer.

Questions marked with are required.

1. Did your undertaking of this E-Learning module allow you to evaluate the heterogeneity of NSCLC and the relationship between molecular features of the tumor and clinical course of the disease? (1-not at all; 5-a lot)

2. Did your undertaking of this E-Learning module allow you to interpret the results of molecular testing to guide treatment selection for patients with NSCLC? (1-not at all; 5-a lot)

3. Did your undertaking of this E-Learning module allow you to appreciate currently available molecular techniques and match them correctly when testing of specific oncogenic alteration(s) in NSCLC patients is needed? (1-not at all; 5-a lot)

4. Please, provide your overall rating of the quality of the education offered by this E-Learning module. (1-poor; 5-excellent)

5. Please, provide your overall rating of the quality of the education offered by this E-Learning module. (1-poor; 5-excellent)

6. Was the information useful and relevant to your work and practice? (1-not at all; 5-completely)

7. Do you feel that the information presented was well balanced and supported by adequate evidence? (1-not at all; 5-absolutely)

8. If you would like to add your personal comments or make suggestions to improve future ESMO E-Learning material, please write in the box below: